Skip to main content

Interpace Diagnostics' ThyraMIR

PDI subsidiary Interpace Diagnostics has launched ThyraMIR, a microRNA gene expression classifier for identifying indeterminate benign and malignant thyroid modules. It is used in combination with the firm's ThyGenX assay to produce a positive or negative cancer test result from thyroid nodule fine needle aspiration procedures.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.